National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Overview
 Organization
  Organizational Charts
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
   Building 33
   RML
  DMID
  VRC
 Director's Page
 Working at NIAID
 Finding People
 Visitor Information


Division of Intramural Research

Overview

The Division of Intramural Research (DIR) conducts basic and clinical research in a wide range of disciplines related to immunology, allergy, and infectious diseases. Our purpose is to make scientific discoveries that promote the development of new vaccines, therapeutics and diagnostics to improve human health. Toward this goal, the DIR works to

  • Expand knowledge of normal immune system components and functions
  • Define mechanisms responsible for abnormal immune function (immunodeficiency, allergy and autoimmunity)
  • Understand the biology of infectious agents (viruses, bacteria, fungi, parasites) and the host response to infection
  • Develop strategies to prevent and treat immunologic, allergic and infectious diseases

DIR scientists study all aspects of infectious diseases such as AIDS, malaria, and influenza, including the causative agent, vectors, and pathogenesis in the human host. They also study prions, the transmissible agents associated with "mad cow" disease and its human form, variant Creutzfeldt-Jakob disease. In recent years, research aimed at developing countermeasures against bioterrorism and emerging infectious diseases has become an increasingly important part of the DIR agenda.

A strong clinical research component is integral to the DIR, allowing key lab discoveries to be rapidly translated into methods to prevent, diagnose, or treat disease. DIR researchers have more than 100 clinical trials ongoing at the NIH Clinical Center on the Bethesda campus or at collaborating U.S. and international sites.

Organization

The DIR has 20 laboratories that conduct peer-reviewed research and 4 branches that focus on malaria vaccine development, new research technologies, and animal care. DIR staff includes 117 principal investigators who lead our research, nearly 90 staff scientists and physicians, and more than 400 technical personnel.

In addition to conducting research, the DIR also provides many laboratory and clinical research training opportunities for both pre- and postdoctoral physicians and scientists. Trainees constitute the largest staff group in the DIR, numbering approximately 500 in 2006.

Location

Most DIR labs are located on the NIH campus in Bethesda and nearby Rockville, Maryland; our other Maryland facilities are located in Frederick, about 40 miles from the main NIH campus. The DIR also has a large research campus in Hamilton, Montana, known as the Rocky Mountain Laboratories (RML). Construction of new biocontainment labs and other improvements are underway at these sites.

back to top


News Releases

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

Experimental TB Drug Explodes Bacteria from the Inside Out
Nov. 27, 2008

NIAID Media Availability: Seizures Following Parasitic Infection Associated with Brain Swelling
Nov. 3, 2008

Persistent Bacterial Infection Exploits Killing Machinery of Immune Cells
Oct. 30, 2008

NIH Scientists Discover Crucial Control in Long-Lasting Immunity
Oct. 10, 2008

DNA of Good Bacteria Drives Intestinal Response to Infection
Oct. 2, 2008

Researchers Find Leishmaniasis Parasites Evade Death by Exploiting the Immune Response to Sand Fly Bites
Aug. 14, 2008

NIAID Media Availability: Exhausted B Cells Hamper Immune Response to HIV
July 14, 2008

NIAID Media Availability: Study Provides New Understanding of Forces behind Seasonal Flu Virus Evolution
April 16, 2008

See More News Releases

 
E-mail Icon E-mail this page
Print Icon Print this page

News Releases

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

Experimental TB Drug Explodes Bacteria from the Inside Out
Nov. 27, 2008

NIAID Media Availability: Seizures Following Parasitic Infection Associated with Brain Swelling
Nov. 3, 2008

Persistent Bacterial Infection Exploits Killing Machinery of Immune Cells
Oct. 30, 2008

NIH Scientists Discover Crucial Control in Long-Lasting Immunity
Oct. 10, 2008

DNA of Good Bacteria Drives Intestinal Response to Infection
Oct. 2, 2008

Researchers Find Leishmaniasis Parasites Evade Death by Exploiting the Immune Response to Sand Fly Bites
Aug. 14, 2008

NIAID Media Availability: Exhausted B Cells Hamper Immune Response to HIV
July 14, 2008

NIAID Media Availability: Study Provides New Understanding of Forces behind Seasonal Flu Virus Evolution
April 16, 2008

See More News Releases